Фоновий візерунок
Зображення ліків

Itraconazol cinfa 100 mg capsulas efg

Про препарат

Introduction

Package Leaflet: Information for the User

itraconazol cinfa 100 mg hard capsules EFG

Read this leaflet carefully before you start to take this medicine because it contains important information for you.

  • Keep this leaflet, as you may need to read it again.
  • If you have any questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not give it to others even if they have the same symptoms as you, as it may harm them.
  • If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.

1. What is itraconazol cinfa and what is it used for

Itraconazol belongs to a group of medicines called “antifungals”.

It is indicated for the treatment of infections caused by fungi of the vagina, skin, mouth, eyes, nails, or internal organs.

2. What you need to know before starting to take itraconazole cinfa

Do not take itraconazole cinfa:

  • If you are allergic to itraconazole or any of the other ingredients of this medicine (listed in section 6).
  • If you have a condition called heart failure (also known as congestive heart failure or CHF). This medicine may worsen it.

If your doctor thinks you should take this medicine, contact him immediately if you notice that you are short of breath, gain weight unexpectedly, have swollen legs, feel unusually tired, or start waking up at night.

  • If you are pregnant,think you may be pregnant or could become pregnant(see section “Pregnancy and breastfeeding”) your doctor will assess whether you should take this medicine.
  • If you are fertile, you should take appropriate contraceptive measures to avoid becoming pregnant during treatment. Because this medicine may remain in the body for some time, you should prolong contraceptive measures until the next menstrual period after completing treatment with this medicine.
  • This medicine cannot be used with some medicines. There are many medicines that interact with itraconazole, see section “Other medicines and itraconazole cinfa” and the list below.

Inform your doctor if you are taking any other medicine.

Do not use itraconazole ifyou are taking any of the following medicines, or within 2 weeks of the end of itraconazole:

Medicines used to treat heart, blood, or circulation problems:

  • aliskiren, eplerenone, lercanidipine, or nisoldipine (for hypertension)
  • bepridil, ivabradine, or ranolazine (for angina)
  • dabigatran or ticagrelor (for blood clots)
  • disopyramide, dofetilide, dronedarone, or quinidine (for irregular heart rhythm)
  • lomitapide, lovastatin, or simvastatin (to reduce cholesterol)
  • sildenafil (for pulmonary hypertension)

Medicines to treat stomach or constipation problems:

  • cisapride (for stomach disorders)
  • domperidone (for nausea and vomiting)
  • naloxegol (for constipation caused by taking opioid analgesics)

Medicines to treat headache, sleep, or mental health problems:

  • dihydroergotamine or ergotamine (alkaloids of ergot used for migraines)
  • midazolam (oral) or triazolam (for sedation or sleep induction)
  • lurasidone, pimozide, quetiapine, or sertindole (for schizophrenia, bipolar disorder, or other mental health disorders)

Medicines to treat urinary problems:

  • darifenacin (for urinary incontinence)
  • fesoterodine or solifenacin (for irritated bladder) when used in patients with certain kidney or liver problems

Medicines to treat allergies:

  • astemizole, mizolastine, or terfenadine (for allergies)

Medicines to treat erection and ejaculation problems:

  • avanafil (for erectile dysfunction)
  • dapoxetine (for premature ejaculation)
  • vardenafil (for erectile dysfunction) when used in men over 75 years old

Other medicines that contain:

  • colchicine (for gout) when used in patients with kidney or liver problems
  • ergometrine (ergonovine) or methylergometrine (methylergonovine) alkaloids of ergot used after delivery
  • eliglustat (for Gaucher's disease) when used in patients who cannot break down certain medicines in the body
  • halofantrine (for malaria)
  • irinotecan (for cancer)
  • isavuconazole (for fungal infections)
  • ombitasvir, paritaprevir, ritonavir with or without dasabuvir (for hepatitis C)

Remember: do not take any of the above medicines during 2 weeks after your last treatment with itraconazole.

Warnings and precautions

Consult your doctor or pharmacist before starting to take itraconazole cinfa:

  • If you have heart problems, consult your doctor. Inform your doctor immediately if you experience shortness of breath, unexpected weight gain, swollen legs, unusual fatigue, or insomnia, as these may be symptoms of heart failure.
  • If you have any liver problems. Your doctor may need to adjust the dose of this medicine. If any of the following symptoms appear during treatment with this medicine, stop taking it and consult your doctor immediately: loss of appetite, nausea, vomiting, fatigue, abdominal pain, jaundice (yellowing of the skin, eyes, mucous membranes, and secretions), dark urine, or pale stools. If you continue to take this medicine, it is likely that your doctor will ask you to have regular blood tests, as rare cases of liver disorders have occurred.
  • If you have any kidney problems, consult your doctor. Your doctor may need to adjust the dose of this medicine.
  • Consult your doctor or seek medical attention immediately if you experience a severe allergic reaction (characterized by a pronounced skin rash, itching, hives, difficulty breathing, and/or facial swelling) while taking itraconazole.
  • Stop taking this medicine and consult your doctor immediately if you become too sensitive to sunlight.
  • Stop taking itraconazole and consult your doctor immediately if you experience a severe skin disorder, such as a generalized rash with skin peeling and blisters in the mouth, eyes, and genitals, or a rash with small pustules or blisters.
  • Contact your doctor if you have neutropenia, HIV/AIDS, or have received an organ transplant. The dose of this medicine may need to be adjusted.
  • If you have had an allergic reaction due to itraconazole or another antifungal medicine (known as azoles), consult your doctor. A hypersensitivity reaction can be recognized, for example, by the appearance of a skin rash, itching, hives, shortness of breath, or difficulty breathing, and/or facial swelling. If you experience a severe allergic reaction, consult your doctor immediately.
  • If you have cystic fibrosis, consult your doctor before taking itraconazole.
  • Stop taking this medicine and consult your doctor immediately if you experience any numbness, tingling, decreased sensitivity, or weakness in your arms and legs (neuropathy).
  • Stop taking this medicine and contact your doctor immediately if you do not hear correctly. In rare cases, temporary or permanent hearing loss has occurred.
  • Inform your doctor if your vision becomes blurry or double, if you hear a buzzing in your ears, if you lose control of your urine, or urinate more than usual.
  • This medicine is not recommended for elderly patients. It may only be prescribed by your doctor in exceptional cases.

Other medicines and itraconazole cinfa

Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medicine, including those purchased without a prescription.

There are medicines thatshould not be takenwhile taking itraconazole. These medicines are listed above under the heading“Do not take itraconazole cinfa”.

It is not recommended to use certain medicines with itraconazole.

Your doctor may decide thatyou should not take some medicines at the same time as itraconazole or within 2 weeks after its completion.

Examples of these medicines are:

Medicines used to treat heart, blood, or circulation problems:

  • apixaban, rivaroxaban, or vorapaxar (for blood clots)
  • atorvastatin (to reduce cholesterol)
  • felodipine (for hypertension)
  • riociguat or tadalafil (for pulmonary hypertension)

Medicines to treat epilepsy, headaches, or mental health problems:

  • phenytoin, carbamazepine, or phenobarbital (antiepileptics)
  • eletriptan (for migraines)
  • St. John's Wort (Hypericum perforatum) (a plant-based medicine used for mental health problems)

Medicines to treat urinary problems:

  • tamsulosin (for male urinary incontinence)
  • tolterodine (for irritated bladder)

Medicines to treat cancer:

  • axitinib, bosutinib, cabazitaxel, cabozantinib, ceritinib, cobimetinib, crizotinib, dabrafenib, dasatinib, docetaxel, ibrutinib, lapatinib, nilotinib, olaparib, pazopanib, regorafenib, sunitinib, trabectedin, trastuzumab emtansine, or vinca alkaloids (e.g., vinflunine, vinorelbine)

Medicines to treat tuberculosis:

  • bedaquiline, isoniazid, rifabutin, or rifampicin (for tuberculosis)

Medicines to treat HIV or hepatitis:

  • efavirenz or nevirapine (for HIV/AIDS)
  • elbasvir/grazoprevir, simeprevir, tenofovir alafenamide fumarate (TAF), tenofovir disoproxil fumarate (TDF) (for HIV or hepatitis)

Medicines used after organ transplantation:

  • everolimus, rapamycin (also known as sirolimus), temsirolimus

Medicines to treat benign prostatic hyperplasia:

  • alfuzosin, silodosin

Medicines to treat respiratory, allergy, or inflammatory problems:

  • ciclesonide (for inflammation, asthma, and allergies)
  • ebastine (for allergies)
  • salmeterol (for asthma or chronic obstructive pulmonary disease, COPD)

Medicines to treat erection and ejaculation problems:

  • tadalafil or vardenafil (when used in men 75 years old or less) (for erectile dysfunction)

Medicines to treat pain:

  • alfentanil, buprenorphine, oxycodone, or sufentanil (for pain)
  • meloxicam (for inflammation and joint pain)

Other medicines that contain:

  • alitretinoin (oral) (for eczema)
  • cabergoline (for Parkinson's disease)
  • cannabis-based products, including medicines (for nausea and vomiting or muscle spasms in patients with multiple sclerosis)
  • cinacalcet (for hyperparathyroidism)
  • dienogest or ulipristal (contraceptives)
  • eliglustat (for Gaucher's disease) when used in patients who cannot break down certain medicines in the body
  • ivacaftor (for cystic fibrosis)
  • methadone (for opioid addiction)

This list is not exhaustive, so you should inform your doctor if you are taking or plan to take any of these medicines or any other medicine.

You should be careful when using itraconazole with certain medicines.It is possible that you may be more likely to experience side effects or that the dose of itraconazole or the other medicine may need to be adjusted. Examples of these medicines are:

Medicines used to treat heart, blood, or circulation problems:

  • bosentan (for pulmonary hypertension)
  • calcium channel blockers such as dihydropyridines, such as amlodipine, isradipine, nifedipine, nimodipine, or diltiazem (for hypertension)
  • verapamil (for hypertension)
  • cilostazol (for circulatory problems)
  • “coumarins” such as warfarin (for blood clots)
  • digoxin (for atrial fibrillation)
  • nadolol (for pulmonary hypertension or angina)

Medicines to treat stomach or diarrhea problems:

  • aprepitant or netupitant (for nausea and vomiting during cancer treatment)
  • loperamide (for diarrhea)
  • antacids such as aluminum, calcium, magnesium, or sodium bicarbonate; H2 receptor antagonists such as cimetidine, ranitidine, or proton pump inhibitors such as lansoprazole, omeprazole, or rabeprazole (for acid reflux)

Medicines to treat sleep or mental health problems:

  • alprazolam, brotizolam, buspirone, or midazolam (when injected into a vein) (for anxiety or sleep induction)
  • zopiclone (for sleep induction)
  • reboxetine or venlafaxine (for depression and anxiety)
  • aripiprazole, cariprazine, haloperidol, or risperidone (for schizophrenia, bipolar disorder, or other mental health disorders)
  • galantamine (for Alzheimer's disease)
  • guanfacine (for attention deficit hyperactivity disorder)

Medicines to treat urinary problems:

  • imidafenacin, fesoterodine, oxybutynin, or solifenacin (for irritated bladder)

Medicines to treat cancer:

  • bortezomib, brentuximab vedotin, busulfan, erlotinib, gefitinib, idelalisib, imatinib, nintedanib, panobinostat, ponatinib, ruxolitinib, or sonidegib

Medicines to treat infections:

  • ciprofloxacin, clarithromycin, or erythromycin (for bacterial infections)
  • delamanid (for tuberculosis)
  • artemether-lumefantrine or quinine (for malaria)
  • praziquantel (for tapeworms and tapeworms)

Medicines to treat HIV or hepatitis:

  • cobicistat, elvitegravir, maraviroc, ritonavir, darunavir with ritonavir, fosamprenavir with ritonavir, indinavir, or saquinavir (for HIV/AIDS)
  • glecaprevir/pibrentasvir (for hepatitis)

Medicines used after organ transplantation:

  • ciclosporin or tacrolimus

Medicines to treat benign prostatic hyperplasia:

  • dutasteride

Medicines to treat respiratory, allergy, or inflammatory problems:

  • bilastine, or rupatadine (for allergies)
  • prednisolone or dexamethasone (oral or injectable medicines for asthma, allergies, or inflammatory disorders)
  • budesonide or fluticasone (for asthma, allergies)

Medicines to treat erection and ejaculation problems:

  • sildenafil (for erectile dysfunction)

Medicines to treat pain:

  • alfentanil, buprenorphine, oxycodone, or sufentanil (for pain)
  • meloxicam (for inflammation and joint pain)

Other medicines that contain:

  • alitretinoin (oral) (for eczema)
  • cabergoline (for Parkinson's disease)
  • cannabis-based products, including medicines (for nausea and vomiting or muscle spasms in patients with multiple sclerosis)
  • cinacalcet (for hyperparathyroidism)
  • dienogest or ulipristal (contraceptives)
  • eliglustat (for Gaucher's disease) when used in patients who cannot break down certain medicines in the body
  • ivacaftor (for cystic fibrosis)
  • methadone (for opioid addiction)

This list is not exhaustive, so you should inform your doctor if you are taking or plan to take any of these medicines, or any other medicine, so that appropriate measures can be taken.

You should have enough acidity in the stomach to ensure the absorption of this medicine. Therefore, medicines that neutralize stomach acid should be taken at least 2 hours before taking itraconazole or 2 hours after taking it. For the same reason, if you are taking medicines that regulate stomach acid production, take itraconazole with a cola drink (see section 3 “How to take itraconazole cinfa”).

If in doubt, consult your doctor or pharmacist.

Taking itraconazole cinfa with food and drinks

Take this medicine immediately after finishing one of the main meals. If you are taking any medicine that regulates stomach acid production, it is recommended to take this medicine with a cola drink.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, or think you may be pregnant or could become pregnant, consult your doctor or pharmacist before using this medicine.

Pregnancy

Consult your doctor or pharmacist before using any medicine.

This medicine will not be used during pregnancy.

If you are fertile and may become pregnant, consult your doctor. You should use effective contraceptive measures to avoid becoming pregnant while taking the medicine. Because this medicine may remain in the body for some time, you should prolong contraceptive measures until the next menstrual period after completing treatment with this medicine (see section 2 “Do not take itraconazole cinfa”).

Breastfeeding

Consult your doctor or pharmacist before using any medicine.

If you are breastfeeding, consult your doctor before taking itraconazole, as small amounts of the medicine may appear in milk.

Driving and operating machinery

Itraconazole may cause dizziness, blurred vision, or hearing loss. If you experience any of these symptoms, do not drive or operate machinery.

itraconazole cinfa contains saccharose

This medicine contains saccharose. If your doctor has told you that you have an intolerance to certain sugars, consult him before taking this medicine.

3. How to take itraconazole cinfa

Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

Remember to take your medication.

Your doctor will indicate the duration of your treatment with this medication. Do not stop treatment before. If you estimate that the medication's action is too strong or too weak, inform your doctor or pharmacist.

You must take this medication immediately after meals, as it is absorbed better. Swallow the capsules whole with a little water. The number of capsules you should take and for how long depends on the type of fungus and the location of the infection. Your doctor will tell you exactly how much itraconazole you should take.

There must be enough acidity in the stomach to ensure the absorption of this medication. Therefore, medications that neutralize stomach acidity should be used two hours after taking this medication or two hours before taking itraconazole. For the same reason, if you are taking medications that regulate acid production in the stomach, take itraconazole with a cola drink.

The following doses are the most frequent:

TYPE OF INFECTION

CAPSULES PER DAY

DURATION

Vaginal infection

2 capsules twice a day

or

2 capsules once a day

1 day

3 days

Skin infection

2 capsules once a day

or

1 capsule once a day

7 days

2 weeks

If the palms of the hands or the soles of the feet are affected, 2 capsules twice a day for 7 days or 1 capsule once a day for 1 month may be needed.

Mouth infections

1 capsule once a day

2 weeks

Eye infections

2 capsules once a day

3 weeks

Internal infections

1 to 4 capsules daily

Longer periods

  • Fingernail infections: Depending on your personal needs, your doctor will choose between continuous or pulsatile treatment.
  • Continuous treatment for foot nail infections:

TYPE OF INFECTION

CAPSULES PER DAY

DURATION

Continuous treatment for nails

2 capsules once a day

3 months

  • Pulsatile treatment for nails:

This consists of 2 capsules twice a day for 1 week; then stop taking itraconazole for 3 weeks. The cycle is then repeated, once for the hands and twice for the feet (with or without infection in the hands). (See the following table)

Week

1

Week

2

Week

3

Week

4

Week

5

Week

6

Week

7

Week

8

Week

9

Week

10

Foot nails with or without hand nail involvement

Take 2 capsules twice a day

No treatment with Itraconazole

Take 2 capsules twice a day

No treatment with Itraconazole

Take 2 capsules twice a day

Stop treatment

Only hand nails

Take 2 capsules twice a day

No treatment with itraconazole

Take 2 capsules twice a day

Stop treatment

For skin infections, lesions will disappear a few weeks after treatment is completed. This is characteristic of fungal spots: the medication eliminates the fungus itself, but the lesion does not disappear until new skin grows.

Nail lesions will disappear from 6 to 9 months after treatment is completed, as the medication only eliminates the fungus itself. The nail must grow, which takes several months. Therefore, do not worry if you do not notice improvement during treatment: the medication remains in your nails for several months and fulfills its mission. Therefore, you should interrupt treatment at the time your doctor indicates, even if you do not see any improvement.

Internal organ infections:Higher doses may be needed and for a long time.

Always follow your doctor's instructions, as he will adapt the treatment to your needs.

Use in children

This medication should not be used in children. It can only be prescribed by a doctor in exceptional cases.

If you take more itraconazole cinfa than you should

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.

In case of accidental overdose, your doctor will apply supportive measures. Itraconazole is not eliminated by hemodialysis. No specific antidotes are known.

If you forgot to take itraconazole cinfa

If you forget to take the medication, take the next dose that corresponds to you and continue treatment as indicated by your doctor. Do not take a double dose to compensate for the missed doses.

If you interrupt treatment with itraconazole cinfa

Do not stop treatment with itraconazole without consulting your doctor, as the symptoms of your disease may reappear or worsen.

If you have any other doubts about the use of this medication, ask your doctor or pharmacist.

4. Possible Adverse Effects

Like all medicines, this medicine can cause side effects, although not everyone will experience them.

If you consider that any of the side effects you are experiencing are serious or if you notice any side effect not mentioned in this leaflet, inform your doctor or pharmacist.

The following side effects have been seen during the marketing of the medicine and clinical trials.

Adverse reactions were classified by frequency using the following convention: Very common (may affect more than 1 in 10 people);

Common (may affect up to 1 in 10 people);

Uncommon (may affect up to 1 in 100 people);

Rare (may affect up to 1 in 1,000 people);

Very rare (may affect up to 1 in 10,000 people);

Frequency not known (cannot be estimated from available data).

Infections and infestations

  • Uncommon: sinusitis (irritation and swelling of the nasal sinuses), upper respiratory tract infection, rhinitis (inflammation of the nasal mucosa that is accompanied by the production of watery mucus and frequent sneezing).

Blood and lymphatic system disorders

  • Rare: leucopenia.

Immune system disorders

  • Uncommon: excessive and allergic hypersensitivity reactions.
    • Rare: anaphylactic reactions (allergic reactions), serum disease (allergy that appears after the injection of some sera and is characterized by the appearance of urticaria, accumulation of fluids, joint pains, fever, and extreme exhaustion), angioneuritic edema (swelling due to the accumulation of fluids that can affect the mouth and upper respiratory tract).

Metabolism and nutrition disorders

  • Rare: increased triglycerides.

Nervous system disorders

  • Common: headache.
  • Rare: tremor, sensation of tingling in the extremities (paresthesia), decreased sensitivity (hypoesthesia), unpleasant taste (bad taste in the mouth).

Eye disorders

  • Rare: visual disturbances (including blurred vision and double vision).

Ear and labyrinth disorders

  • Rare: permanent or temporary hearing loss, subjective sensation of noise in the ear.

Cardiac disorders

  • Rare: congestive heart failure.

Respiratory, thoracic and mediastinal disorders

  • Rare: labored breathing, difficulty breathing (dyspnea).

Gastrointestinal disorders

  • Common: abdominal pain, nausea.
  • Uncommon: vomiting, discomfort associated with meals, diarrhea, constipation, accumulation of gases in the intestine (flatulence).
  • Rare: pancreatitis.

Hepatobiliary disorders

  • Uncommon: abnormal liver function.
  • Rare: elevated bilirubin in the blood (hyperbilirubinemia), severe hepatotoxicity (including cases of acute severe liver failure).

Skin and subcutaneous tissue disorders

  • Uncommon: urticaria, rash, itching
  • Rare: toxic epidermal necrolysis (severe skin disease characterized by skin rash and the appearance of blisters and scales), Stevens-Johnson syndrome (severe skin, mucous membrane, and eye inflammation), a severe skin disorder (generalized exfoliative dermatitis with skin peeling and blisters in the mouth, eyes, and genitals, or generalized exfoliative dermatitis with small pustules or blisters), erythema multiforme (skin disease characterized by the appearance of vesicles, blisters, etc.), dermatitis exfoliativa (skin disease characterized by peeling), leukocytoclastic vasculitis (inflammation of the blood vessel walls), alopecia (hair loss), photosensitivity (exaggered skin response to sunlight).

Renal and urinary disorders

  • Rare: increased frequency of urination.

Reproductive and breast disorders

  • Uncommon: menstrual disorders.
  • Rare: erectile dysfunction.

General disorders and administration site conditions

  • Rare: edema (fluid accumulation).

Investigations

  • Rare: increased creatine phosphokinase in the blood (parameter that measures liver function).

Description of certain side effects

The following side effects are associated with itraconazole and have been reported in clinical trials of itraconazole oral and/or intravenous solution, excluding the side effect "inflammation at the injection site" which is specific to the intravenous route.

Blood and lymphatic system disorders:granulocytopenia, thrombocytopenia (decreased platelet count).

Immune system disorders:anaphylactoid reaction.

Metabolism and nutrition disorders:hyperglycemia (elevated blood sugar), hyperkalemia (elevated potassium), hypokalemia (decreased potassium), hypomagnesemia (decreased magnesium).

Mental and behavioral disorders:sensation of confusion or disorientation.

Nervous system disorders:peripheral neuropathy (affecting peripheral nerves with a sensation of tingling, numbness, or weakness in the extremities), dizziness, somnolence.

Cardiac disorders:heart failure, left ventricular insufficiency, tachycardia (rapid heart rate).

Vascular disorders:hypertension (high blood pressure), hypotension (low blood pressure).

Respiratory, thoracic and mediastinal disorders:pulmonary edema, hoarseness, cough.

Gastrointestinal disorders:gastrointestinal disorder.

Hepatobiliary disorders:liver insufficiency, hepatitis, jaundice (yellowing of the skin, eyes, mucous membranes, and secretions).

Skin and subcutaneous tissue disorders:erythematous rash (exanthema eritematoso), excessive sweating.

Musculoskeletal and connective tissue disorders:muscle or joint pain (myalgia), joint pain (arthralgia).

Renal and urinary disorders:renal insufficiency, urinary incontinence (urine loss).

General disorders and administration site conditions:generalized edema (fluid accumulation in the body tissues), facial edema, chest pain, fever, pain, fatigue, chills.

Investigations:increased alanine aminotransferase, increased aspartate aminotransferase, increased alkaline phosphatase in the blood, increased lactate dehydrogenase in the blood, increased urea in the blood, increased gamma-glutamyltransferase, increased liver enzymes, abnormal urine analysis.

Other side effects in children

Based on data from pediatric clinical trials, the most frequently reported side effects were: headache, vomiting, abdominal pain, diarrhea, abnormal liver function, low blood pressure, nausea, and urticaria.

In general, the nature of the side effects is similar to that observed in adult patients, although the incidence is higher in pediatric patients.

Reporting of side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not mentioned in this leaflet. You can also report them directly through the Spanish System for the Vigilance of Medicinal Products for Human Use: https://www.notificaram.es.By reporting side effects, you can contribute to providing more information on the safety of this medicine.

5. Conservation of itraconazole cinfa

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.

Do not store at a temperature above 30°C.

Medicines should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.

6. Contents of the packaging and additional information

Composition of itraconazole cinfa

  • The active ingredient is itraconazole. Each capsule contains 100 mg of itraconazole.
  • The other components (excipients) are:

Contents of the capsule: sugar spheres (containing saccharose, cornstarch and purified water), poloxamer 188 and hypromellose.

Capsule coating: gelatin, purified water, blue FD & C2, indigotin, cochineal extract (E-132), quinoline yellow (E-104) and titanium dioxide (E-171).

Appearance of the product and contents of the packaging

Hard gelatin capsules, with green opaque cap and body, containing beige-yellow microspheres.

It is presented in Aluminio/Aluminio blisters. Each package contains 7, 14 or 100 (clinical package) capsules.

Only some package sizes may be commercially available.

Marketing authorization holder and responsible manufacturer

Marketing authorization holder:

Laboratorios Cinfa, S.A.

Carretera Olaz-Chipi, 10. Polígono Industrial Areta

31620 Huarte (Navarra) - Spain

Responsible manufacturer:

LICONSA, S.A.

Avda. Miralcampo, Nº 7 Polígono Industrial Miralcampo

19200 Azuqueca de Henares (Guadalajara), Spain

Laboratorios Cinfa, S.A.

Carretera Olaz-Chipi, 10. Polígono Industrial Areta

31620 Huarte (Navarra) - Spain

Last review date of this leaflet: July 2021

Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/

You can access detailed and updated information about this medicine by scanning the QR code included in the leaflet and packaging with your smartphone. You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/65773/P_65773.html

QR code to: https://cima.aemps.es/cima/dochtml/p/65773/P_65773.html

Країна реєстрації
Активна речовина
Потрібен рецепт
Так
Виробник
Склад
Esferas de azucar (sacarosa y almidon de maiz) (265,300 mg mg)
Информация носит справочный характер и не является медицинской рекомендацией. Перед приёмом любых препаратов проконсультируйтесь с врачом. Oladoctor не несёт ответственности за медицинские решения, принятые на основе этого контента.

Поговоріть з лікарем онлайн

Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.

5.01 відгук
Doctor

Анна Морет

Дерматологія18 років досвіду

Анна Морет — лікарка-дерматолог і дерматовенеролог із міжнародною сертифікацією. Спеціалізується на дерматології дорослих і дітей, венерології, естетичному догляді за шкірою та загальній медицині. Проводить онлайн-консультації, базуючись на доказовій медицині та індивідуальних потребах кожного пацієнта.

Сфера допомоги охоплює: • захворювання шкіри: екзема, акне, розацеа, дерматити, псоріаз • проблеми з волоссям і шкірою голови: випадіння волосся, лупа, себорейний дерматит • дитяча дерматологія — від новонароджених до підлітків • венерологія та інфекції, що передаються статевим шляхом (ІПСШ) • естетичні запити: вікові зміни шкіри, неінвазивні косметологічні процедури • алергічні реакції та підвищена чутливість шкіри • перевірка родимок, оцінка новоутворень, скринінг раку шкіри • поради щодо догляду за шкірою та підбір індивідуальної космецевтики

Поєднуючи дерматологію із загальноклінічним досвідом, Анна Морет надає всебічну допомогу, що охоплює як стан шкіри, так і супутні захворювання. Має сертифікацію Канадської ради естетичної медицини, що підтверджує міжнародний підхід до естетичної дерматології.

Записатися на онлайн-консультацію
5.01 відгук
Doctor

Аліна Цуркан

Сімейна медицина12 років досвіду

Аліна Цуркан — ліцензована лікарка сімейної медицини в Португалії. Проводить онлайн-консультації для дорослих і дітей, допомагаючи пацієнтам у вирішенні широкого спектра щоденних медичних запитів з професійним підходом і увагою до деталей.

Звернутися можна з такими станами: • респіраторні інфекції: застуда, грип, бронхіт, пневмонія • Захворювання очей: кон’юнктивіт (інфекційний і алергічний) • ЛОР-захворювання: синусит, отит, тонзиліт • проблеми з травленням: гастрит, кислотний рефлюкс, синдром подразненого кишківника (СПК) • інфекції сечових шляхів та інші поширені інфекції • хронічні захворювання: артеріальна гіпертензія, діабет, порушення функції щитоподібної залози • головний біль і мігрень

Окрім лікування симптомів, Аліна Цуркан приділяє особливу увагу профілактиці та ранньому виявленню захворювань. Проводить планові огляди, надає медичні рекомендації, здійснює повторні консультації та виписує рецепти — з урахуванням індивідуальних потреб кожного пацієнта.

Її підхід — комплексний, уважний і адаптований до кожного етапу життя пацієнта: від гострих станів до довготривалого контролю здоров’я.

Записатися на онлайн-консультацію
5.09 відгуків
Doctor

Андрій Попов

Терапія6 років досвіду

Андрій Попов — ліцензований в Іспанії терапевт і фахівець із лікування болю. Проводить онлайн-консультації для дорослих, допомагаючи впоратися з хронічним і гострим болем, а також із широким спектром загальних медичних запитів.

Спеціалізується на діагностиці та лікуванні болю, що триває понад 3 місяці або суттєво знижує якість життя. Працює з такими станами, як: • хронічний біль будь-якого походження • мігрень і повторювані головні болі • біль у шиї, спині, попереку та суглобах • посттравматичний біль після травм, розтягнень або операцій • невропатичний біль, фіброміалгія, невралгії

Окрім знеболення, Андрій Попов допомагає пацієнтам у веденні загальних медичних станів, зокрема: • респіраторні інфекції (застуда, бронхіт, пневмонія) • артеріальна гіпертензія, порушення обміну речовин, цукровий діабет • профілактичні огляди та контроль загального стану здоров’я

Онлайн-консультація триває до 30 хвилин і включає детальний аналіз симптомів, рекомендації щодо обстежень, формування індивідуального плану лікування та подальший супровід за потреби.

Андрій Попов дотримується принципів доказової медицини, поєднуючи клінічний досвід із уважним і персоналізованим підходом до кожного пацієнта.

Записатися на онлайн-консультацію
5.01 відгук
Doctor

Євген Яковенко

Загальна хірургія11 років досвіду

Євген Яковенко — ліцензований лікар-хірург і терапевт в Іспанії. Спеціалізується на загальній і дитячій хірургії, внутрішній медицині та лікуванні болю. Проводить онлайн-консультації для дорослих і дітей, поєднуючи хірургічну практику з терапевтичним супроводом.

Сфера медичної допомоги охоплює: • діагностику та лікування гострого й хронічного болю • перед- і післяопераційний супровід, оцінку ризиків, контроль стану • хірургічні захворювання: грижі, жовчнокам’яна хвороба, апендицит • консультації з дитячої хірургії: вроджені стани, дрібні втручання • травми: переломи, ушкодження м’яких тканин, обробка ран • онкохірургія: консультації, планування, супровід після лікування • внутрішні захворювання: патології серцево-судинної та дихальної систем • ортопедичні стани, реабілітація після травм • інтерпретація результатів візуалізації для хірургічного планування

Євген Яковенко активно займається науковою діяльністю та міжнародною співпрацею. Член Асоціації хірургів Німеччини (BDC), співпрацює з Асоціацією сімейних лікарів Лас-Пальмаса та Німецьким консульством на Канарських островах. Регулярно бере участь у міжнародних медичних конференціях і публікує наукові статті.

Поєднуючи багатопрофільний досвід із доказовою медициною, він надає точну та індивідуалізовану допомогу для пацієнтів із різними медичними запитами.

Записатися на онлайн-консультацію
Переглянути всіх лікарів

Слідкуйте за новинами та заощаджуйте на послугах

Поради лікарів, оновлення платформи та знижки для підписників.

Слідкуйте за нами в соцмережах